SCHEMBL26435252

SCHEMBL26435252

c1ccc(-c2nc(-c3cccc4ccc5ccccc5c34)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.44
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 5/20 0.44
HPGD P15428 5/20 0.44
HSD17B10 Q99714 4/20 0.44
TSHR P16473 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPK1 P28482 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
TP53 P04637 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
ATM Q13315 1/20 0.44
ABCG2 Q9UNQ0 3/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435259 0.97 MAPT (0.43) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23759408 0.96 MAPT (0.43) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24307039 0.95 MAPT (0.41) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL26435261 0.93 TDP1 (0.40) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24472866 0.93 MAPT (0.42) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23759453 0.93 TDP1 (0.43) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24951385 0.93 MAPT (0.42) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24306440 0.93 TDP1 (0.42) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24306509 0.93 TDP1 (0.49) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL26435771 0.93 ALDH1A1 (0.39) MAPTALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 MAPT 2425/4885ALDH1A1 1532/4885KDM4E 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.